with controlled algorithms that allow amputees to walk more naturally and
comfortably) to surgical robots that can operate with a magnitude of precision
that cannot be replicated by the most skillful surgeon (for use in areas like
cardiothoracic, gynecology, urology, orthopedics, neurology, and general
surgery). Since the introduction of Intuitive Surgical's da Vinci operating
system, the robotic surgery industry revenue has experienced healthy
growth; this market alone is projected to be approximately $6 billion by 2020,
growing at a CAGR of 10.2%. The desire to adopt minimally invasive surgery
techniques that result in less blood loss and pain should foster greater demand
for such robotic equipment. Further out in the future, we hope to witness the
practical applications of bio-engineered DNA robots or swimming nanobots
that can carry drug payloads to target cancers or other conditions for the ailing
patient.
Summary
The linkage with Taiwan and AI is important. There are ongoing AI projects
currently at the university level and in government and research labs, such as at
ITRI. There are opportunities for investors and start-ups in the US to collaborate
with these institutions, and WI Harper can help link researchers in Taiwan with
the relevant parties in the US. In addition, Taiwan strategic and venture investors
have been and are investing in the field of robotics and AI. Taiwan companies
play an integral role in the overall AI/ robotics value chain, especially in the areas
of semiconductors, components and sub-systems that are integrated into the final
intelligent product.
Although large amounts of investments have already poured into AI recently,
investing in this space continues to have tremendous upside. Investors, however,
should remain cautious and judicious in their approach evaluating the many
investment opportunities. Many of the technologies in this field are still emerging
and not ready for prime time. WI Harper is uniquely positioned to take advantage
76
